Cohort study of fatty acid synthase expression and patient survival in colon cancer.
暂无分享,去创建一个
M. Loda | J. Meyerhardt | E. Giovannucci | S. Ogino | A. Chan | C. Fuchs | T. Kawasaki | K. Nosho | G. Kirkner | A. Chan
[1] E. Araki,et al. AMPK and cell proliferation – AMPK as a therapeutic target for atherosclerosis and cancer , 2006, The Journal of physiology.
[2] Y. Mo,et al. Fatty acid synthase gene is up-regulated by hypoxia via activation of Akt and sterol regulatory element binding protein-1. , 2008, Cancer research.
[3] M. Loda,et al. Fatty acid synthase overexpression in colorectal cancer is associated with microsatellite instability, independent of CpG island methylator phenotype. , 2007, Human pathology.
[4] M. Loda,et al. The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer. , 2004, Cancer cell.
[5] J. Menéndez,et al. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis , 2007, Nature Reviews Cancer.
[6] Stephan Gripp,et al. Survival prediction in terminally ill cancer patients by clinical estimates, laboratory tests, and self-rated anxiety and depression. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] M. Loda,et al. Distinct molecular features of colorectal carcinoma with signet ring cell component and colorectal carcinoma with mucinous component , 2006, Modern Pathology.
[8] M. Loda,et al. CpG island methylator phenotype-low (CIMP-low) in colorectal cancer: possible associations with male sex and KRAS mutations. , 2006, The Journal of molecular diagnostics : JMD.
[9] A. Rashid,et al. Elevated expression of fatty acid synthase and fatty acid synthetic activity in colorectal neoplasia. , 1997, The American journal of pathology.
[10] F. Kuhajda,et al. Fatty acid synthase and cancer: new application of an old pathway. , 2006, Cancer research.
[11] Shuji Ogino,et al. Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis. , 2006, The Journal of molecular diagnostics : JMD.
[12] F. Marandino,et al. Immunohistochemical expression of fatty acid synthase, apoptotic-regulating genes, proliferating factors, and ras protein product in colorectal adenomas, carcinomas, and adjacent nonneoplastic mucosa. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[13] C. Bogardus,et al. A novel missense substitution (Val1483Ile) in the fatty acid synthase gene (FAS) is associated with percentage of body fat and substrate oxidation rates in nondiabetic Pima Indians. , 2004, Diabetes.
[14] M. Gorospe,et al. Pharmacological inhibition of fatty acid synthase activity produces both cytostatic and cytotoxic effects modulated by p53. , 2001, Cancer research.
[15] N. Sathiakumar,et al. Using the National Death Index to obtain underlying cause of death codes. , 1998, Journal of occupational and environmental medicine.
[16] H. Yatsuya,et al. A prospective study of body size and colon cancer mortality in Japan: The JACC Study , 2004, International Journal of Obesity.
[17] P. B. Eveleth,et al. Physical Status: The Use and Interpretation of Anthropometry. Report of a WHO Expert Committee , 1996 .
[18] Shuji Ogino,et al. Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. , 2007, The New England journal of medicine.
[19] P. Visca,et al. Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients , 1996, Cancer.
[20] R. Houlston,et al. Systematic review of microsatellite instability and colorectal cancer prognosis. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] P. Laird,et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer , 2006, Nature Genetics.
[22] T. Gansler,et al. Increased expression of fatty acid synthase (OA-519) in ovarian neoplasms predicts shorter survival. , 1997, Human Pathology.
[23] M. Moroni,et al. Epidermal growth factor receptor gene copy number and clinical outcome of metastatic colorectal cancer treated with panitumumab. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] P. Febbo,et al. Fatty acid synthase expression defines distinct molecular signatures in prostate cancer. , 2003, Molecular cancer research : MCR.
[25] C. Haiman,et al. Association of methylenetetrahydrofolate reductase gene polymorphisms and sex-specific survival in patients with metastatic colon cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] J. Nelson,et al. Increased fatty acid synthase expression and activity during progression of prostate cancer in the TRAMP model , 2003, The Prostate.
[27] E. Jaffee,et al. Fatty acid synthase inhibitors are chemopreventive for mammary cancer in neu-N transgenic mice , 2005, Oncogene.
[28] J. Meyerhardt,et al. Influence of body mass index on outcomes and treatment‐related toxicity in patients with colon carcinoma , 2003, Cancer.
[29] S. Kridel,et al. Fatty acid synthase inhibitors: new directions for oncology , 2007, Expert opinion on investigational drugs.
[30] Todd Thornburg,et al. Dietary fat’gene interactions in cancer , 2007, Cancer and Metastasis Reviews.
[31] E. Rimm,et al. Validity of Self‐Reported Waist and Hip Circumferences in Men and Women , 1990, Epidemiology.
[32] Manuel Hidalgo,et al. Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[33] M. Loda,et al. Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample. , 2007, The Journal of molecular diagnostics : JMD.
[34] M. Loda,et al. Sensitive sequencing method for KRAS mutation detection by Pyrosequencing. , 2005, The Journal of molecular diagnostics : JMD.
[35] M. Gunter,et al. Obesity and colorectal cancer: epidemiology, mechanisms and candidate genes. , 2006, The Journal of nutritional biochemistry.
[36] S. Ogino,et al. Molecular classification and correlates in colorectal cancer. , 2008, The Journal of molecular diagnostics : JMD.
[37] Jeffrey W. Smith,et al. Orlistat Is a Novel Inhibitor of Fatty Acid Synthase with Antitumor Activity , 2004, Cancer Research.
[38] D. English,et al. Effect of physical activity and body size on survival after diagnosis with colorectal cancer , 2005, Gut.
[39] S Srivastava,et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. , 1998, Cancer research.
[40] S. Kridel,et al. Inhibition of fatty acid synthase induces endoplasmic reticulum stress in tumor cells. , 2007, Cancer research.
[41] J. Menéndez,et al. Inhibition of Tumor-associated Fatty Acid Synthase Hyperactivity Induces Synergistic Chemosensitization of HER-2/neu-Overexpressing Human Breast Cancer Cells to Docetaxel (taxotere) , 2004, Breast Cancer Research and Treatment.
[42] R. Labianca,et al. Nuclear factor-kB tumor expression predicts response and survival in irinotecan-refractory metastatic colorectal cancer treated with cetuximab-irinotecan therapy. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[43] N. Wolmark,et al. Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer. , 2006, Journal of the National Cancer Institute.
[44] M. Loda,et al. CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies , 2006, Gut.
[45] M. Loda,et al. Combined analysis of COX-2 and p53 expressions reveals synergistic inverse correlations with microsatellite instability and CpG island methylator phenotype in colorectal cancer. , 2006, Neoplasia.
[46] J. C. Barrett,et al. The utility of genetically altered mouse models for nutrition and cancer chemoprevention research. , 2005, Mutation research.
[47] Graham A Colditz,et al. Physical activity and survival after colorectal cancer diagnosis. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[48] Norman Wolmark,et al. Prognostic and predictive roles of high-degree microsatellite instability in colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project Collaborative Study. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[49] C. Boland. Clinical uses of microsatellite instability testing in colorectal cancer: an ongoing challenge. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[50] Graham A. Colditz,et al. The Nurses' Health Study: lifestyle and health among women , 2005, Nature Reviews Cancer.